Patent: 9,029,321
✉ Email this page to a colleague
Summary for Patent: 9,029,321
| Title: | Methods and compositions for targeting adipose cells in mammals |
| Abstract: | Methods and compositions are presented for use in diagnostic, imaging or targeting of therapeutic agents to treat obesity/adiposity-associated disorders, where such as compositions and methods identify and use peptides to selectively target adipose tissue stromal cells in mammals, both in vitro and in vivo. |
| Inventor(s): | Kolonin; Mikhail G. (Houston, TX), Daquinag; Alexes (Houston, TX), Zhang; Yan (Houston, TX) |
| Assignee: | Board of Regents of the University of Texas (Austin, TX) |
| Application Number: | 14/007,836 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,029,321
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2031-03-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
